This medication may cause a condition known as tardive dyskinesia. In some cases, this condition may be permanent. Tardive dyskinesia is more likely to occur when metoclopramide is used for longer than 3 months, in high doses, or when used in the elderly (especially elderly women). Contact your doctor immediately if you develop any unusual uncontrolled movements (especially of the face, mouth, tongue, arms or legs)....
Read moreThe FDA has issued a new warning about the use of Reglan or Metaclopramide, a medication that may be used to treat Gastroesophageal Reflux... Read more »
As most of you know the FDA just released a new "Black Box Warning" for metaclopramide or Reglan. In my opinion this warning is long... Read more »
The Food and Drug Administration (FDA) recently began posting a listing of prescription medications that may have potential risks or safety... Read more »
If you take prescription opioid medications for your chronic pain, please read this alert.The FDA is advising patients and health care... Read more »
The FDA has analyzed reports of suicidal behavior or ideation from placebo-controlled clinical studies of eleven drugs used to treat... Read more »
The U.S. Food and Drug Administration (FDA) is requiring a black box warning be added the label for the heartburn drug Reglan. The FDA says the drug... Read more »
A reader asks Joe and Teresa Graedon of The People's Pharmacy if the reflux drug Reglan could be used to enhance breast-milk production. The Graedons... Read more »
One reader of The People's Pharmacy says that the long-term use of the heartburn drug Reglan led her friend to develop tardive dyskinesia. According... Read more »
People who suffer a stroke due to a blocked brain artery and who are given the clot-busting drug tPA are much more likely to have excess bleeding if... Read more »
The U.S. Food and Drug Administration (FDA) has issued an alert on the correct and safe use of Tussionex Pennkinetic Extended-Release Suspension. The... Read more »